Monday, December 10, 2012

• Morilla-Giner: Selective Investing Paramountat Bloomberg (Mon, Dec 10)

Thursday, December 6, 2012

• Where Next for GlaxoSmithKline's Dividend?at Motley Fool (Thu, Dec 6)

Wednesday, December 5, 2012

• Lundbeck to Begin Late-Stage Trials on Alzheimer’s Drug Mid-2013at Bloomberg (Wed, Dec 5)

Tuesday, December 4, 2012

• Duchess of Cambridge Shows Violent Response of Pregnancyat Bloomberg (Tue, Dec 4)
• 5 Shares to Beat George Osborneat Motley Fool (Tue, Dec 4)
• Glaxo Doubts GLP-1s Would Be Cleared as Drugs for Obesityat Bloomberg (Tue, Dec 4)
• U.S. Barred From Prosecuting Off-Label Sales of Drugsat Bloomberg (Tue, Dec 4)
• Drugmakers Nudged by FDA to Find Childhood Cancer Curesat Bloomberg (Tue, Dec 4)
• Million Days Lost to Diarrhea Spur Military’s Cure Searchat Bloomberg (Tue, Dec 4)

Sunday, December 2, 2012

• Neil Woodford's Latest Buys and Sellsat Motley Fool (Sun, Dec 2)

Saturday, December 1, 2012

• What This Dividend Ratio Is Telling Us Nowat Motley Fool (Sat, Dec 1)

Thursday, November 29, 2012

• Whooping Cough Cases in U.K. This Year Are 10 Times Peak in 2008at Bloomberg (Thu, Nov 29)

Wednesday, November 28, 2012

• European Crisis Spurs Drugmakers to Pull Back Treatmentsat Bloomberg (Wed, Nov 28)

Tuesday, November 27, 2012

• Theravance’s Vibativ May Have Risk for Pneumonia Patientsat Bloomberg (Tue, Nov 27)
• Harvard Doctor Turns Felon After Lure of Insider Tradingat Bloomberg (Tue, Nov 27)
• Wachtell, Clifford Chance, Paul Weiss: Business of Lawat Bloomberg (Tue, Nov 27)
• 5 FTSE 100 Dividend-Raising Starsat Motley Fool (Tue, Nov 27)

Monday, November 26, 2012

• GlaxoSmithKline Announces 653-Million-Pound Emerging-Market Investmentat Motley Fool (Mon, Nov 26)
• GSK Consumer Nigeria Gains as Parent to Buy Shares: Lagos Moverat Bloomberg (Mon, Nov 26)

Wednesday, November 21, 2012

• Stocks for the Long Run: GlaxoSmithKline vs. the FTSE 100at Motley Fool (Wed, Nov 21)

Monday, November 19, 2012

• Ligand Rises on FDA Blood Drug Approval for Hepatitis Cat Bloomberg (Mon, Nov 19)
• The 3 Biggest Risks Facing GlaxoSmithKlineat Motley Fool (Mon, Nov 19)

Friday, November 16, 2012

• Novartis Bexsero Meningitis Shot Wins EU Agency’s Backingat Bloomberg (Fri, Nov 16)
• Dynavax Falls After Vaccine Fails to Win Panel Backingat Bloomberg (Fri, Nov 16)

Thursday, November 15, 2012

• Glaxo Pays $90 Million to Settle States’ Avandia Claimsat Bloomberg (Thu, Nov 15)

Add GSK.L News to My Yahoo!